Medical device companies produce a wide variety of products such as wheelchairs, defibrillators, pacemakers, stents, and infusion pumps.

The medical device industry is highly regulated, and companies must invest in constant research and development in order to maintain a competitive edge.

The in vitro diagnostics (IVD) instruments, kits, reagents, and related supplies market is projected to grow to $74 billion by 2022.

Diagnostics providers are actively expanding into markets in developing countries, where there is a rising demand for quality healthcare services. However, stable in vitro diagnostics market growth is also expected in developed countries.

Life sciences tends to be a source of competitive and investor interest, because of its potential role in fighting disease and increasing human health. We asked one of our publishers, Kalorama Information, to talk about its recently published market studies. The publisher noted the following areas of health care.

The American Association for Clinical Chemistry (AACC) is about to host its 69th Annual Scientific Meeting & Clinical Lab Expo, which will take place from July 31 through August 4.

According to the AACC website, the expo showcases a variety of cutting-edge technology with more than 200 new product introductions each year. With so much happening in the field, what should attendees expect to see?

Clinical laboratories are a critical component of health care. Approximately 80% of physicians’ diagnoses are a result of laboratory tests, according to Kalorama Information, a healthcare market research firm.

Common routine tests include cholesterol level tests, HIV tests, pap tests, pregnancy tests, and substance abuse tests. Clinical lab testing is also used to monitor diseases and drug treatments. Specialty testing, which is often more costly, may include genetics, immunology, oncology, endocrinology, and other segments.

Kalorama Information provides life sciences industry research for leading drug, diagnostic, and medical device companies. Kalorama uses expert healthcare analysts who are highly knowledgeable and adept at discovering current trends. This publisher is regularly cited as a credible source by major news outlets such as The Wall Street Journal, Associated Press, The New York Times, Genetic Engineering News, Contract Pharma, and Becker’s Hospital Review.

This year, Kalorama Information has released a number of new market research reports on key diagnostics and medical device industries. Three major reports are profiled below.

As patients take a more proactive role in their own health care, direct-to-consumer (DTC) laboratory testing is becoming increasingly popular. DTC genetic tests allow consumers to access information about their genetics without necessarily involving healthcare professionals in the process. 

A number of established and emerging companies are competing in this growing market. Kalorama Information, a healthcare market research firm, recently profiled a variety of prominent market participants in its report The Market for Direct-to-Consumer Genetic Testing and Routine Laboratory Testing. This blog post highlights 9 of these companies that are among the leaders in the industry.

MarketResearch.com is a leading provider of business intelligence, offering users access to timely information about hundreds of industries. In partnership with Kalorama Information, MarketResearch.com provides high-quality research and analysis to key decision makers in life science firms.

Life science market research includes broad topics such as biotechnology, healthcare, pharmaceuticals, medical devices, and diagnostics. New and established companies need to be aware of influential changes that may alter how healthcare is delivered and the patient's experience and outcomes. Our white papers and market research reports explain the market sectors and healthcare trends that matter most. Below is a list of our latest white papers with insights into this rapidly changing industry.

An essential component of clinical care, in-vitro diagnostics tests can detect a wide range of diseases, infections, and conditions, from sexually-transmitted diseases to different types of cancer.

In the next five to ten years, the in-vitro diagnostics markets (IVD) in Europe, Japan, and the U.S. are expected to experience only modest growth. In contrast, developing and emerging markets will drive increased demand for IVD as a growing middle class and aging population seek out healthcare services.

Market Variation within the Global Cord Blood Industry

Cord blood banks now exist within nearly every developed country, as well within most developing nations. However, there is still significant variation within the industry. First, there is the divide between private and public cord blood banking, in which private companies serve individual families, while public banks serve the broader population. Additionally, some cord blood banks receive only units from nearby hospitals and birthing centers, while others allow mail-in units from a diverse geographic region.